Central nervous system tolerance to boron neutron capture therapy with p-boronophenylalanine
1997

CNS Tolerance to Boron Neutron Capture Therapy with p-Boronophenylalanine

Sample size: 27 publication Evidence: moderate

Author Information

Author(s): GM Morris, JA Coderre, PL Micca, CD Fisher, J Capala, JW Hopewell

Primary Institution: University of Oxford; Brookhaven National Laboratory

Hypothesis

The study evaluates the effects of boron neutron capture irradiation on the central nervous system using different doses of p-boronophenylalanine (BPA).

Conclusion

The study concluded that the compound biological effectiveness (CBE) factor decreases as the blood to CNS boron concentration ratio increases.

Supporting Evidence

  • Boron levels in blood, spinal cord, and brain were measured over a 3-hour period after BPA injection.
  • The CBE factor was found to decrease as the blood to CNS boron concentration ratio increased.
  • ED50 values for the incidence of myelopathy were calculated from probit-fitted curves.
  • Simulations indicated a significant therapeutic advantage could be obtained by using higher BPA doses.

Takeaway

This study looked at how a special treatment for brain tumors works in rats, showing that using more of a certain medicine can help deliver more radiation to the tumor without hurting the brain too much.

Methodology

Young adult male Fischer 344 rats were used to assess the biodistribution of boron-10 in blood, spinal cord, and brain after administering different doses of BPA.

Limitations

The study was conducted on rats, which may not fully represent human responses to the treatment.

Participant Demographics

Young adult male Fischer 344 rats, weighing 260-290 g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication